์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ
Merck

Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.

Bioorganic & medicinal chemistry letters (2007-05-26)
Naohisa Ogo, Shinya Oishi, Kenji Matsuno, Jun-ichi Sawada, Nobutaka Fujii, Akira Asai
์ดˆ๋ก

Inhibition of Eg5 represents a novel approach for the treatment of cancer. Here, we report the synthesis and structure-activity relationship of S-trityl-L-cysteine (STLC) derivatives as Eg5 inhibitors. Some of these derivatives such as 4f demonstrated enhanced inhibitory activity against Eg5 and induced mitotic arrest with characteristic monoastral spindles in HeLa cells.

MATERIALS
์ œํ’ˆ ๋ฒˆํ˜ธ
๋ธŒ๋žœ๋“œ
์ œํ’ˆ ์„ค๋ช…

Sigma-Aldrich
Boc-Cys(Trt)-OH, 97%
Sigma-Aldrich
S-Carboxymethyl-L-cysteine
Sigma-Aldrich
S-Methyl-L-cysteine, substrate for methionine sulfoxide reductase A
Sigma-Aldrich
L-Cysteine, โ‰ฅ97%, FG
SAFC
L-Cysteine
Sigma-Aldrich
Fmoc-Cys(Trt)-OH, ≥95.0% (sum of enantiomers, HPLC)
Sigma-Aldrich
S-Benzyl-L-cysteine, 97%
Sigma-Aldrich
L-Cysteine, 97%
Sigma-Aldrich
L-Cysteine, BioUltra, โ‰ฅ98.5% (RT)
Sigma-Aldrich
L-Cysteine, from non-animal source, BioReagent, suitable for cell culture, โ‰ฅ98%